
Rytary
RYTARY is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
We offer a $25 copay with commercial insurance and a valid prescription. Offer does not apply to Medicare, Medicaid, or other government-funded insurance.